Randall Kaye, Senior VP, Chief Medical Officer at AVANIR PHARMACEUTICALS, INC. (AVNR), sold 10,000 shares at $3.80 ($38K) on 2010-12-06, disclosed to the SEC on 2010-12-08.
Scheduled sale ($38k) by Senior VP, Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| LBPH | SELL | 2024-08-13 | $1.2M | — | Filing → |
| LBPH | BUY | 2024-08-13 | $2K | — | Filing → |
| AXSM | BUY | 2015-12-24 | $9K | — | Filing → |